Nicole A. Favis

Evolution of and Evolutionary Relationships between Extant Vaccinia Virus Strains

Li Qin, Nicole A. Favis, Jakub K. Famulski et al. · Journal of Virology · 2014 · 84 citations · Full text

Life Sciences, Evolutionary Biology, Microbiology +17

Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models

Kyle Potts, Chad R. Irwin, Nicole A. Favis et al. · EMBO Molecular Medicine · 2017 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

Human Concentrative Nucleoside Transporter 3 Transfection with Ultrasound and Microbubbles in Nucleoside Transport Deficient HEK293 Cells Greatly Increases Gemcitabine Uptake

Robert J. Paproski, Sylvia Y.M. Yao, Nicole A. Favis et al. · PLoS ONE · 2013 · 33 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A Whole-Genome RNA Interference Screen for Human Cell Factors Affecting Myxoma Virus Replication

Wondimagegnehu M. Teferi, Kristopher Dodd, R.A. Maranchuk et al. · Journal of Virology · 2013 · 17 citations

Life Sciences, Biology, Molecular Biology +17

Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast Cancer

Brittany A. Umer, Ryan S. Noyce, Brian C. Franczak et al. · Cancer Immunology Research · 2020 · 15 citations · Full text

Medicine, Immunology, Oncology +17